News
Incit news
Our news
Discover all the news of the INCIT laboratory: conferences, seminars, scientific publications, evolution of projects and teams.
ReNAissance: revolutionizing antiviral treatments with messenger RNA
ReNAissance is one of the projects selected by the Impact Santé program, an initiative led by Inserm as part of France 2030. The aim of this program is to support the most daring, high-impact health research, by funding projects that push back the boundaries of current science and medicine.
"Enterotoxigenic bacteria, biofilms and colorectal cancer immunotherapy".
F. Altare's team has invited Prof. Franck Housseau (Johns Hopkins University) on May 28, 14.00. Seminar title: Enterotoxigenic bacteria, biofilms and colorectal cancer immunotherapy.
"When Antibiotics Fail: Understanding Bacterial Persistence During Infection".
The Angevine team has invited Charlotte Michaux from U1230 to Rennes on April 23 at 11.00. Title of her seminar: When Antibiotics Fail: Understanding Bacterial Persistence During Infection.
ReNAissance: revolutionizing antiviral treatments with messenger RNA
ReNAissance is one of the projects selected by the Impact Santé program, an initiative led by Inserm as part of France 2030. The aim of this program is to support the most daring, high-impact health research, by funding projects that push back the boundaries of current science and medicine.
DARVAC: Inserm impact Santé
Team 3 from INCIT Lab Inserm U1302 (Nantes) is part of the Inserm Impact Santé project DARVAC "Development of vaccines offering innovative early protection against non-viral cancers" based on ghost (Dark) proteins. The project is led by Jerome Galon, with Michel...
"Deciphering the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus".
Dr Marc Blondel (Faculté de Médecine et des Sciences de la Santé de l'UBO (Brest), invited by Team 2, will give a seminar entitled: Decrypting the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus, on May 14 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes.
"Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids".
Dr Gilles Marodon (Inserm U1135 | CIMI-PARIS | SiRiC Curamus), invited by Team 3, will give a seminar entitled: Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids , on March 14 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes
"2 prizes for Incit at the Go Immuno congress - December 11 & 12, 2023".
INCIT was honored at the "Go Immuno" conference organized by Labex IGO in December. Margaux Verdon (team 1) was awarded the prize for best poster, while Gwenann Cadiou (team 3) won the prize for best oral communication!
"C. Rabu's HDR on June 16".
Catherine Rabu (team 3) will present her HDR entitled: Antigènes de tumeurs issus de LongNonCoding RNA: identification, modes d'expression et utilisation thérapeutique on June 16 at 14.30, rooms 1, 2, 3 at IRS2, Nantes.
"Emerging innate immune sensors in microbial detection".
Dr. Etienne Meunier (Institute of Pharmacology & Structural Biology (IPBS) will give a seminar entitled: Emerging innate immune sensors in microbial detection, on June 12 at 2:00 pm - Rooms 1, 2, 3 - IRS2, Nantes
"Investigating the interaction between T cell metabolism and physical ability in aged mice: translation to humans."
Dr Isabelle Satney (Centre Méditerranéen de Médecine Moléculaire) will give a seminar entitled: Study of the interaction between T cell metabolism and physical capacities in aged mice: transposition to humans, May 11 at 11:00 am - Rooms 1, 2, 3 - IRS2, Nantes